{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:34:46Z","timestamp":1782902086306,"version":"3.54.5"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,6,1]],"date-time":"2008-06-01T00:00:00Z","timestamp":1212278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The American Journal of Geriatric Pharmacotherapy"],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1016\/j.amjopharm.2008.05.001","type":"journal-article","created":{"date-parts":[[2008,8,4]],"date-time":"2008-08-04T14:02:12Z","timestamp":1217858532000},"page":"96-99","source":"Crossref","is-referenced-by-count":13,"title":["Adverse effects of propafenone after long-term therapy with the addition of citalopram"],"prefix":"10.1016","volume":"6","author":[{"given":"Angeles","family":"Garcia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjopharm.2008.05.001_bib1","first-page":"CD005049","article-title":"Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation","author":"Lafuente-Lafuente","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1378\/chest.125.2.377","article-title":"Long-term maintenance of normal sinus rhythm in patients with current symptomatic atrial fibrillation: Amiodarone vs propafenone, both in low doses","volume":"125","author":"Kochiadakis","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib3","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0026-895X(25)13410-X","article-title":"Identification and characterization of the cytochrome P450 enzymes involved in N-dealkylation of propafenone: Molecular base for interaction potential and variable disposition of active metabolites","volume":"43","author":"Botsch","year":"1993","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib4","first-page":"2550","article-title":"A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraven-tricular tachycardia and paroxysmal atrial fibrillation","volume":"92","author":"Cobbe","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib5","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0002-9149(96)00332-3","article-title":"Safety and tolerability of long-term propafenone therapy for supraventricular tachyarrhythmias","volume":"78","author":"Podrid","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib6","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2165\/00002512-200118050-00006","article-title":"Selective serotonin reuptake inhibitors for late-life depression: A comparative review","volume":"18","author":"Solai","year":"2001","journal-title":"Drugs Aging"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib7","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1097\/00004714-200008000-00007","article-title":"Effect of selec-tive serotonin reuptake inhibitors on the oxidative metabolism of propafenone: In vitro studies using human liver microsomes","volume":"20","author":"Hemeryck","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib8","first-page":"484","article-title":"Depression, falls, and risk of fracture in older women","volume":"159","author":"Whooley","year":"1999"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib9","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1365-2796.1995.tb01225.x","article-title":"Propafenone in a usual dose produces severe side-effects: The impact of genetically determined metabolic status on drug therapy","volume":"238","author":"Morike","year":"1995","journal-title":"J Intern Med"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib11","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1097\/00000441-200008000-00016","article-title":"Propafenone-induced ataxia: Report of three cases","volume":"320","author":"Odeh","year":"2000","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.amjopharm.2008.05.001_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/106002809502900606","article-title":"Probablepropafenone-induced transient global amnesia","volume":"29","author":"Jones","year":"1995","journal-title":"Ann Pharmacother"}],"container-title":["The American Journal of Geriatric Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1543594608000196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T08:59:10Z","timestamp":1738313950000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1543594608000196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,6]]}},"alternative-id":["S1543594608000196"],"URL":"https:\/\/doi.org\/10.1016\/j.amjopharm.2008.05.001","relation":{},"ISSN":["1543-5946"],"issn-type":[{"value":"1543-5946","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}